Brief: Gracell Biotechnologies Reports Fourth Quarter And Full Year 2022 Unaudited Financial Results, And Provides Corporate Update

Gracell Biotechnologies

13/03/2023 12:27

March 13 (Reuters) - Gracell Biotechnologies Inc
 GRCL.O :
    * GRACELL BIOTECHNOLOGIES REPORTS FOURTH QUARTER AND FULL
YEAR
2022 UNAUDITED FINANCIAL RESULTS, AND PROVIDES CORPORATE UPDATE
    * QTRLY LOSS PER SHARE US$0.06 
    * ON TRACK TO COMMENCE A CHINA IIT FOR SMART CAR-T GC506 IN
CLAUDIN18.2-POSITIVE SOLID TUMORS IN FIRST HALF OF 2023
    * WELL-FUNDED WITH CASH RUNWAY TO END OF 2024
    * AS OF DECEMBER 31, 2022, CO HAD RMB1,458.2 MILLION
(US$211.4
MILLION) IN CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
    * Q4 EARNINGS PER SHARE VIEW $-0.13 -- REFINITIV IBES DATA

Source text for Eikon:  ID: 

 ((Reuters.Briefs@thomsonreuters.com;))